Viewing Study NCT00003858



Ignite Creation Date: 2024-05-05 @ 11:22 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00003858
Status: WITHDRAWN
Last Update Posted: 2016-07-13
First Post: 1999-11-01

Brief Title: Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence
Sponsor: Alliance for Clinical Trials in Oncology
Organization: Alliance for Clinical Trials in Oncology

Study Overview

Official Title: A Phase II Trial of Adjuvant Mitoxantrone NSC 301739 for High Risk Patients Following Radical Prostatectomy
Status: WITHDRAWN
Status Verified Date: 2016-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: The study was not activated
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: RATIONALE Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die Giving chemotherapy after surgery may kill more tumor cells

PURPOSE Phase II trial to study the effectiveness of mitoxantrone given after surgery in treating patients who have prostate cancer that is at high risk for recurrence
Detailed Description: OBJECTIVES I Assess the feasibility of enrolling patients with adenocarcinoma of the prostate at high risk for recurrence following radical prostatectomy in an adjuvant mitoxantrone trial II Determine if this adjuvant therapy results in a delay in time to failure or a decrease in the number of treatment failures compared to historical controls in this patient population

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
CLB-99801 None None None
CDR0000067021 REGISTRY NCI Physician Data Query None